WHO ICTRP trial
The effect of monitoring of tobramycin levels in blood in patients with cystic…
NL-OMON20263 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON20263 |
|---|---|
| Public title | The effect of monitoring of tobramycin levels in blood in patients with cystic fibrosis. |
| Scientific title | The effect of Therapeutic Drug Monitoring of tobramycin in patients with cystic fibrosis. |
| Primary sponsor | AMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Cystic fibrosis |
| Interventions | No interventions: retrospective, observational study |
| Registration date | May 4, 2014 |
| Target size | 35 |
| Secondary IDs | NL4420;NTR4544;Kemper : E.M. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: